Company profile: Ingenium Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of drug development, operating as a subsidiary of Probiodrug AG, an integrated drug development company; founded in 1998 as a spin-off from the German Human Genome Project.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ingenium Pharmaceuticals
Camurus
HQ: Sweden
Website
- Description: Provider of innovative specialty medicines, with research-based development and commercialization aimed at improving treatment outcomes and quality of life for patients with serious and chronic diseases; based in Lund.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Camurus company profile →
Andor
HQ: United Kingdom
Website
- Description: Provider of scientific imaging equipment, designing and manufacturing high-performance cameras (EMCCD, CCD, sCMOS), integrated multimodal confocal microscopy systems for life sciences, spectroscopy platforms based on Czerny-Turner or Echelle spectrometers with advanced detectors, optical cryostats (<3 K to 500 K), photostimulation tools, and imaging/analysis software for scientific research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Andor company profile →
Nautilus Biotechnology
HQ: United States
Website
- Description: Provider of a high-throughput, low-cost proteome analysis platform enabling single-molecule protein counting and comprehensive quantification across the human proteome. Offers the Nautilus Proteome Analysis Platform, the PrISM theoretical framework, and multi-affinity probes to analyze up to 10 billion protein molecules per run with an expected dynamic range spanning up to 9 orders of magnitude.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nautilus Biotechnology company profile →
SAMDI Tech
HQ: United States
Website
- Description: Provider of contract assay services offering label-free biochemical assays for drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SAMDI Tech company profile →
BBI Solutions
HQ: United Kingdom
Website
- Description: Provider of raw materials and test technology platforms for the diagnostics market, offering monoclonal and polyclonal antibodies for antigen identification, custom antibody manufacturing and conjugation services, matched antibody pairs for capture and detection, and Novarum, a smartphone platform that turns a phone into a diagnostic test reader to read and share rapid test results at the point of care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BBI Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ingenium Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ingenium Pharmaceuticals
2.2 - Growth funds investing in similar companies to Ingenium Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ingenium Pharmaceuticals
4.2 - Public trading comparable groups for Ingenium Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →